FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
2,583 letters match. Newest first.
-
TobaccoJSMT LLC d/b/a VaporFI
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
TobaccoWalker Enterprises, LLC d/b/a MaddCatt Vapor
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
DrugsAdvanced Pharmaceutical Technology
FDA warns Advanced Pharmaceutical Technology over drug manufacturing quality failures, sterility controls, and unapproved drugs.
High risk -
Tobaccosmokewonderland.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
Tobaccothefinesteliquid.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
DrugsNeva Global Grup Sanayi Ic Ve Dis Ticaret Anonim Sirketi
FDA warns Turkish OTC drug maker Neva Global over inadequate component testing, process validation, stability, and quality oversight.
High risk -
DrugsInternational Laboratories Corp
FDA warned International Laboratories Corp, a Thai drug manufacturer, over fabricated lab records and inadequate CGMP controls.
High risk -
DrugsAspen Pharmacare Holdings Limited
FDA warns Aspen subsidiary over sterile OTC drug manufacturing failures including impurity testing, aseptic practices, data integrity, and environmental monitoring.
High risk -
DevicesRed Oak Instruments, LLC
Red Oak Instruments marketed RU-Fit dynamometer for concussion screening without FDA clearance and had MDR and quality system violations.
High risk -
DrugsRite-Kem Incorporated
FDA warned Rite-Kem over inadequate current good manufacturing practice testing of over-the-counter drugs, including hand sanitizers and antimicrobial products.
High risk -
DrugsVegewax Candleworx Ltd.
FDA warns Vegewax Candleworx over CGMP violations in OTC drug manufacturing, including inadequate component testing and OOS investigations.
High risk -
TobaccoFT DISTRO INC., d/b/a Happy Global
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
TobaccoToro Imports, LLC
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
TobaccoGood Smokes LLC, d/b/a Vape N Vapor
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
TobaccoElectric Clouds, LLC
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
TobaccoBusiness Trading Company LLC, d/b/a Vapor Tonics
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
TobaccoCool Vape LLC
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
TobaccoA-Z Tobacco Inc, d/b/a A-Z Tobacco
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
Tobaccogreenrushsmokeshop.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
Tobaccovapingby.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
DrugsShree Jaya Laboratories PVT. LTD.
FDA warned Shree Jaya Laboratories after an inspection found CGMP deviations in API and intermediate manufacturing, including dirty equipment and torn batch records.
High risk -
DrugsLinghai ZhanWang Biotechnology Co., Ltd
Linghai ZhanWang Biotechnology's OTC drugs, including antimicrobial wipes, fail manufacturing quality rules; FDA cites missing tests.
High risk -
DevicesQ’Apel Medical, Inc.
Q’Apel Medical marketed an uncleared modified HIPPO stroke aspiration device and had quality system violations, FDA says.
High risk -
DrugsRight Value Drug Stores, LLC dba Carie Boyd Pharmaceuticals
FDA warned outsourcing facility Carie Boyd Pharmaceuticals in Irving, TX that sterile drug production had airflow, media fill and contamination control failures.
High risk -
TobaccoYou Suck Vapes
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
TobaccoYou Suck Vapes
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
TobaccoThe Tiki Hut Vapes
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
TobaccoMcVapour LLC
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
DrugsProRx, LLC
FDA warns ProRx, LLC about insanitary sterile compounded-drug production and manufacturing-quality failures.
High risk -
DrugsGranules India Limited
FDA warned Granules India in Telangana, India, that its finished drugs are adulterated after inspectors found cross-contamination in air ducts, bird droppings and torn records.
High risk -
DrugsChem-Tech, Ltd.
Chem-Tech, Ltd. lacked adequate investigations and clean equipment for its OTC drug.
High risk -
FoodMariscos Procesados - CAMPRESA - S.A.
Mariscos Procesados-CAMPRESA's frozen vacuum-packed mahi-mahi fillets lacked required seafood HACCP controls, FDA says.
High risk -
TobaccoElk River Vapor Shop
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
TobaccoThe Vapor Club LLC
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
TobaccoLoveli Design, LLC d/b/a Alice in Vapeland
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
FoodRadhaswamy Inc. dba Raja Foods LLC
FDA warned Radhaswamy Inc. dba Raja Foods that it lacked required foreign supplier verification for most imported foods, including rice and candy.
High risk -
TobaccoRoute 66 Vapor
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
TobaccoSteep Slope Vape Supply
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
TobaccoSmoke and Vape Inc d/b/a Backdoor Smoke Shop
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
TobaccoWalker Enterprises, LLC d/b/a MaddCatt Vapor
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
TobaccoA-Z Tobacco Inc d/b/a A-Z Tobacco and Vapor
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
DrugsMarshalls Traditional Healthcare CC
Marshalls Traditional Healthcare, an OTC drug maker in South Africa, lacked finished-product release testing and process validation.
High risk -
DrugsABR Laboratory LLC
FDA warned ABR Laboratory, a contract drug testing lab, that unverified microbial test methods and missed investigations made tested drugs adulterated.
High risk -
DrugsTyche Industries Ltd
FDA warned Tyche Industries over falsified records, dirty equipment, and untested raw materials at its API plant.
High risk -
DrugsJagsonpal Pharmaceuticals Limited
Jagsonpal Pharmaceuticals cited for API CGMP and listing failures after Indian inspection, leading to US import alert.
High risk -
DrugsAmWiner & Raphe Holdings, LLC dba rapheGenerics Corp
FDA cited rapheGenerics for manufacturing-quality failures and unapproved minoxidil hair regrowth drugs.
High risk -
DevicesRobbins Instruments, LLC
Robbins Instruments marketed Dermo-Jet Needleless Injector without FDA clearance and had quality system violations.
High risk -
TobaccoGorilla Vapes of East Brunswick
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
DrugsChengdu Innovation Pharmaceutical Co., Ltd.
FDA warned Chengdu Innovation Pharmaceutical over CGMP (manufacturing quality rules) failures in API (drug ingredient) manufacturing, including no identity testing of incoming materials.
High risk -
DrugsWuhu Nuowei Chemistry Co., Ltd.
FDA cited Wuhu Nuowei Chemistry for API CGMP deviations in impurity testing, stability data, and cleaning, and placed products on import alert.
High risk